Article citationsMore>>

Y. Bang, E. L. Kwak, A. Shaw, et al., “Clinical Activity of the Oral ALK Inhibitor, PF-02341066, in ALK-Positive Patients with Non-Small Cell Lung Cancer,” Journal of Clinical Oncology, Vol. 28, No, 18, 2010, p. 3.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top